Shane P. Sanders joined Robbins LLP upon graduating law school, embracing the firm’s fight for shareholder rights and corporate accountability. Focusing his practice on shareholder derivative and securities class actions, Mr. Sanders has litigated a broad range of matters on behalf of shareholders, including cases addressing stock option backdating, the subprime mortgage crisis, board entrenchment and elections, executive compensation, corporate takeovers, violations of the Foreign Corrupt Practices Act and myriad forms of fraud, including violations of federal securities laws related to insider trading and companies’ initial public offerings. He has played a major role in securing monetary recoveries and innovative governance reforms designed to improve the independence, rigor, and transparency of corporate governance at dozens of publicly traded companies. Mr. Sanders has been recognized as a Super Lawyer for his commitment and dedication to his clients.
Mr. Sanders received his Juris Doctor from the University of San Diego School of Law. During law school, he served as a law clerk at the San Diego County Public Defender’s Office. Mr. Sanders received his Bachelor of Arts degree in Sociology from the University of California, Santa Barbara. He was a member of UCSB’s Division I track and field team, specializing in the 400-meter dash.
EDUCATION
ADMISSIONS
RECOGNITION
Mr. Sanders served as lead plaintiffs’ counsel in the consolidated state derivative action alleging that, from the third quarter of 2015 through the first half of 2017, certain Under Armour officers and directors made or permitted the publication of statements intended to create the impression of continued strong demand that had fueled the Company’s year-over-year quarterly revenue growth. Plaintiffs allege the defendants knew when these statements were made that Under Armour had been relying on unsustainable sales practices to mask declining demand that created revenue holes in future quarters and undercut future sales and margins by damaging relationships with full-price retailers. After eight years of litigation, Mr. Sanders helped to obtain $8,900,000 for Under Armour and significant corporate governance enhancements, including the creation of a disclosure committee, audit committee enhancements, and insider trading policy enhancements. Kenney, et al. v. Plank, et al., Case No. 24-C-18-003939 (Balt. City Cir. Ct. Md. Aug. 14, 2025)
Mr. Sanders served as co-lead counsel for plaintiffs in shareholder derivative litigation involving breach of fiduciary duty and other claims arising from alleged false and misleading statements concerning known issues with the Company’s Alaris infusion pump system. Mr. Sanders led a coordinated multi-jurisdictional litigation effort that culminated in a $9 million payment to Becton Dickinson and significant governance reforms, including enhanced oversight designed to prevent regulatory compliance violations and product-related issues, improvements to the Company’s disclosure controls, the addition of an independent corporate governance expert, and the implementation of strengthened vetting processes to ensure Board independence. In re Becton, Dickinson and Company Stockholder Derivative Litigation, No. 2:20-cv-15474-SRC-CLW (D.N.J. Aug. 11, 2025)
Mr. Sanders served as lead counsel in shareholder derivative litigation involving alleged breaches of fiduciary duty arising from the defendants’ failure to address the company’s regulatory non-compliance, which led to the termination of Emergent‘s contracts to manufacture COVID-19 vaccine bulk drug substance as part of the U.S. government’s “Operation Warp Speed” pandemic response and left the Company on the brink of insolvency. Mr. Sanders led a coordinated multi-jurisdictional litigation effort that culminated in a $15 million payment to Emergent and significant governance reforms tailored to address the oversight lapses and internal controls deficiencies Plaintiffs contend left the Company unable to demonstrate compliance with U.S. Food and Drug Administration drug manufacturing standards. In re Emergent BioSolutions Inc., Stockholder Derivative Litigation, Case No. 8:21-cv-01595-DLB (D. Md. Aug. 6, 2025)
Mr. Sanders represented plaintiffs who are shareholders in Wells Fargo & Co in a derivative shareholder action alleging breaches of fiduciary duty by certain Wells Fargo officers and directors stemming from the purported mismanagement of and noncompliance with myriad consent orders and failures relating to the corporate governance and risk management framework of the Company. Plaintiffs defeated numerous dispositive motions and a writ of mandate filed in a California appeals court, intervened in federal court to secure a ruling that streamlined all proceedings into the California state court, negotiated the production of two million pages of discovery, worked through complex privilege issues with federal regulators to secure additional documents, and negotiated a settlement providing for a $100 million cash payment to the Company. This settlement is the largest payment made directly to a company in a derivative action in California state court history. The settlement also acknowledged that plaintiffs’ allegations in the derivative action caused significant corporate governance reforms related to Wells Fargo’s risk structure, programs, policies, and procedures, additional training for employees, expanded and enhanced oversight of risk management by Wells Fargo’s Board of Directors, and changes to the composition of Wells Fargo’s Board of Directors. Himstreet, et al. v. Scharf, et al., Case No. CGC-22-599223 (Cal. Super. Ct.-S.F. Cnty. July 24, 2025)
Mr. Sanders served as co-lead counsel for plaintiffs who sued for damages in connection with false and misleading statements regarding adverse mortality experience and corresponding reserves for life insurance policies acquired from The Hartford Financial Services Group, Inc. Plaintiffs alleged that defendants knew that adverse mortality experience would require material adjustments in the mortality exceptions, yet misled investors during Prudential‘s June 2019 investor conference by stating that the mortality experience was in the range of normal volatility and below previous experience. After protracted litigation and numerous discovery-related victories in matters of first impression under New Jersey law, Robbins LLP secured a $10 million cash recovery for the Company. In approving the settlement, the Honorable Stanley R. Chesler noted that the settlement was “not only a reasonable recovery, it is a remarkable recovery and is a tribute to plaintiffs and plaintiffs’ lawyer efforts in this case.” (Transcript of Motion on Final Settlement Approval at 19-20). In re Prudential Financial Inc. Derivative Litigation, No. 2:20-cv-12772-SRC-CLW (Dist. NJ June 9, 2025)
Shane P. Sanders served as part of the Robbins LLP team that acted as additional counsel to the federal plaintiffs in this coordinated litigation on behalf of Altria Group Inc. in which plaintiffs alleged that Altria’s $12.8 billion investment in Juul Labs, Inc. undermined the Company’s hard-fought reputational progress with regulators and lawmakers after decades of marketing tobacco products and funding misleading research about the harmful effects of smoking. Mr. Sanders’ perseverance on behalf of Altria contributed to Robbins LLP’s success in achieving a hard-fought settlement that required multiple mediations, months of continued discussions, informal mediation conferences, and extensive document review of over 35 million pages. When achieved, the settlement contemplated a comprehensive and global resolution of the actions. The settlement requires Altria to commit to funding $117 million over five years, with a minimum spend of $20 million each year to address policy and governance measures relating to youth prevention and transaction oversight that may include: (i) positive youth development programs; (ii) smoking and vaping cessation treatment; and (iii) point of sale age verification technology. In re Altria Group, Inc. Derivative Litigation, No: 3:20cv772(DJN) (E.D. VA, Feb. 20, 2023)
SOUTHERN COMPANY
Mr. Sanders led the firm’s efforts on behalf of plaintiffs in this federal derivative action arising out of certain of Southern Company’s officers’ and directors’ breaches of fiduciary duty in connection with the Company’s attempted construction and subsequent decommissioning of the world’s first commercial-scale power plant to integrate coal gasification and carbon sequestration, which resulted in significant financial loss. After extensive discovery, including multiple mediator-facilitated settlement negotiations, Mr. Sanders helped achieve a settlement that provides substantial benefits to Southern, including the implementation of significant corporate governance reforms that target the alleged lapses in Board-and management-level supervision of Large Capital Projects and reduce the likelihood the Company will suffer similar lapses in the future, which “have the potential to contribute hundreds of millions of dollars in value to Southern over time.” In re The Southern Company Shareholder Derivative Litigation, No 1:17-CV-725-MHC (N. Dist. Of Georgia June 9, 2022)
Mr. Sanders served as co-lead counsel on behalf of the federal shareholder plaintiffs in a shareholder derivative action that alleged defendants breached their fiduciary duties to Twitter and its stockholders by making materially false and/or misleading statements about Twitter’s user growth and user management prospects and that certain individual defendants profited on their inside information. After extensive litigation, including multiple mediations and months of settlement discussions, Mr. Sanders helped to secure a $38 million settlement to Twitter and substantial corporate governance reforms, including enhancements to the Disclosure and Audit Committees, the creation of an independent Chief Compliance Officer position, and improved compliance training and insider trading policies. In re Twitter, Inc. S’holder Derivative Litig., No. 1:18-cv-00062-VAC-MPT (D. Del. July 27, 2021)
Mr. Sanders played a central role in Robbins’s LLP prosecution of derivative claims brought on behalf of Fifth Street Finance Corp. The allegations centered on Fifth Street’s relationship with its external investment advisor, Fifth Street Asset Management Inc. (“FSAM”). Plaintiffs asserted that certain Fifth Street and FSAM officers and directors caused Fifth Street to pursue reckless asset growth strategies, employ aggressive accounting and financial reporting practices, and pay excessive fees to its investment advisor to inflate the perceived value of FSAM prior to FSAM’s initial public filing. Mr. Sanders was instrumental in the investigation and early settlement negotiations through which Robbins LLP secured advisory fee reductions worth at least $30 million to Fifth Street, and comprehensive corporate governance, oversight, and conflicts management enhancements. In re Fifth Street Finance Corp. Shareholder Derivative Litigation, Lead Case No. 3:15-cv-01795-RNC (D. Conn. Dec. 13, 2016)
ALCOA CORPORATION
Mr. Sanders helped litigate a shareholder derivative action alleging that the company’s officers and directors permitted Alcoa Corporation to bribe members of the Bahraini government to receive market-premium prices for alumina from Aluminium Bahrain B.S.C. in violation of the Foreign Corrupt Practices Act (“FCPA”). Mr. Sanders led the discovery efforts, which included the review of tens of thousands of pages of non-public documents and information and an in-depth investigation into the company’s compliance practices. Mr. Sanders also played a leading role in the settlement discussions that led to Alcoa’s adoption of a comprehensive compliance program involving multi-level approach to managing FCPA and other anti-corruption programs. Rubery v. Kleinfeld, No. 2:12-cv-00844-DWA (W.D. Pa. Jan. 20, 2015)
KOSS CORPORATION
Mr. Sanders’ efforts in shareholder derivative litigation on behalf of Koss Corporation alleging unjust enrichment by receipt of compensation and director remuneration from the company in the midst of an employee’s embezzlement were instrumental in beating defendants’ motion to dismiss based on allegations of demand futility. After extensive discovery, Koss’s directors agreed to pay nearly $1 million back to the company and implement corporate governance reforms to their board structure, external auditor and audit committee function, and accounting and internal audit functions. In re Koss Corporation Shareholder Derivative Litigation, Lead Case No. 10-cv-002422 (Wis. Cir. Ct.-Milwaukee Cnty. Dec, 22, 2011)
PANERA BREAD COMPANY
Mr. Sanders played a leading role in shareholder derivative litigation brought on behalf of Panera Bread to address allegations that the company’s officers and directors misleadingly increased Panera’s earnings guidance while demand for the company’s products was declining, and engaged in insider trading. Mr. Sanders briefed and argued the opposition to defendants’ motion to dismiss, defeating the motion, and conducted extensive discovery. He helped negotiate the settlement, which secured valuable corporate governance reforms designed to address and prevent recurrence of the alleged wrongdoing, including the creation of new committees to provided increased involvement by senior management in the company’s expansion and growth, and increased responsibilities to the audit committee. Paschetto v. Shaich, No. 08-SL-CC00805 (Mo. Cir. Ct.-St. Louis Cnty. April 8, 2011)
HECKMANN CORPORATION
Mr. Sanders was part of the team whose efforts led to the creation of a Special Litigation Committee of Heckmann Corporation’s board of directors to evaluate and consider claims arising from the company’s disastrous acquisition of a China-based water company. Mr. Sanders briefed and argued the demurrer oppositions, persuading the court that demand on Heckmann’s board would have been futile. Thereafter, Mr. Sanders helped secure a settlement that included the adoption of reforms to enhance transaction due diligence and disclosure practices to ensure adequate investigation of a target’s internal controls over accounting and financial reporting. Hess v. Heckmann et al., No. INC 10010407 (Cal. Super. Ct.-Riverside Cty. Nov. 18, 2010)
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2026 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.